Kim TM, Lakhani NJ, Soumerai J, Kamdar M, et al. Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 study. Haematologica 2025 Apr 10. doi: 10.3324/haematol.2024.286208.
PMID: 40207726